Histidyl-Glycyl-Glutamyl-Glycyl-Threonyl-Phenylalanyl-Threonyl-Seryl-Aspartyl-Leucyl-Seryl-Lysine Trifluoroacetate

METABOLITES

Product Details

CAT No.# CS-O-13852
Category Metabolites
CAS NA
Molecular Weight 1375.34
Molecular Formula C56H83F3N15O22
Purity: >98%
Synonyms: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys Trifluotate; 29-(2-(2-Amino-3-(1H-imidazol-5-yl)propanamidminobutyl)-20-benzyl-11-carboxymethyl)-17,23-bis(1-hydroxyethyl)-5,14-bis(hydroxymethyl)-8-isobutyl-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24,27-nonaazadotricontane-1,32-dioc cid Trifluorocetate; (2S,5S,8S,11S,14S,17S,20S,23S,29S)-29-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)cetamido)-2-(4-aminobutyl)-20-benzyl-11-carboxymethyl)-17,23-bis((R)-1-hydroxyethyl)-14-(hydroxymethyl)-8-isobutyl-4,7,10,13,16,19,22,25,28-nonaoxo-5-((2,2,2-trifluorocetoxy)methyl)-3,6,9,12,15,18,21,24,27-nonaazadotricontane-1,32-dioc cid
Application Notes: Histidyl-Glycyl-Glutamyl-Glycyl-Threonyl-Phenylalanyl-Threonyl-Seryl-Aspartyl-Leucyl-Seryl-Lysine Trifluoroacetate is a metabolite from Exenatide trypsin digestion. Exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor
References: Pugazhenthi, U. et al.: Diabetol., 53, 2357 (2010); Li,c. et al.: Biche,. Biophys. Res.comm., 400, 563 (2010); Lupi, R. et al.: Diab. Obes. Metab., 10, 515 (2008); Kim, T.H. et al.: Biconj.chem., 22, 625 (2011);
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
Related Results for 'Histidyl-Glycyl-Glutamyl-Glycyl-Threonyl-Phenylalanyl-Threonyl-Seryl-Aspartyl-Leucyl-Seryl-Lysine Trifluoroacetate'

- API Standards of Exenatide
- Stable Isotopes of Exenatide
- Metabolites of Exenatide
- Impurities of Exenatide
- Glucuronides of Exenatide
- Intermediates of Exenatide

PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
[H]N[C@@H](CC1=CN=CN1)C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(N[C@H](C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(N[C@H](C(N[C@H]([C]=O)CCCCN)=O)CO)=O)CC(C)C)=O)=O)CO)=O)[C@@H](C)O)=O)=O)[C@@H](C)O)=O)=O)CCC(O)=O)=O)=O.O=C(C(F)(F)F)O



This page contains information about Histidyl-Glycyl-Glutamyl-Glycyl-Threonyl-Phenylalanyl-Threonyl-Seryl-Aspartyl-Leucyl-Seryl-Lysine Trifluoroacetate Cas NA and its Metabolites.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."